clinical trial · NCT04246489
Bintrafusp Alfa Monotherapy in Platinum-Experienced Cervical Cancer
EMD Serono Research & Development Institute, Inc.·phase2·completed·n = 146
Uterine Cervical NeoplasmsBintrafusp alfa
brief summary
The main purpose of this study was to evaluate clinical efficacy and safety of bintrafusp alfa in participants with advanced, unresectable cervical cancer with disease progression during or after platinum-containing chemotherapy.
started
Mar 30, 2020
primary completion
Apr 5, 2022
completion
Dec 14, 2022
last updated
Oct 23, 2023
official title
A Phase II, Multicenter, Open Label Study of Bintrafusp Alfa (M7824) Monotherapy in Participants With Advanced, Unresectable Cervical Cancer With Disease Progression During or After Platinum-Containing Chemotherapy
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol